Publications

Vision for Switzerland as a pharma hub in 2030: «Switzerland is still Europe's leading pharma hub in 2030. It benefits from high-quality medical innovation and is able to fund this innovation in the long run and sustainably. The pharmaceutical industry is a key contributor to the prosperity and quality of life of people in Switzerland.»

The Innovation Report 2025 presents the latest drug approvals in Switzerland, key research trends and the tangible benefits of innovative therapies for patients and the healthcare system.